{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T18:24:05Z","timestamp":1751912645593,"version":"3.37.3"},"reference-count":61,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2017.4225","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T13:34:01Z","timestamp":1513085641000},"source":"Crossref","is-referenced-by-count":2,"title":["No erythropoietin-induced growth is observed in non-small cell lung cancer cells"],"prefix":"10.3892","author":[{"given":"Armin","family":"Frille","sequence":"first","affiliation":[{"name":"Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8252-9279","authenticated-orcid":false,"given":"Katharina","family":"Leithner","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8189-3634","authenticated-orcid":false,"given":"Andrea","family":"Olschewski","sequence":"additional","affiliation":[{"name":"Ludwig Boltzmann Institute for Lung Vascular Research, 8010 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2834-7466","authenticated-orcid":false,"given":"Horst","family":"Olschewski","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wohlk\u00ef\u00bf\u00bdnig","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andelko","family":"Hrzenjak","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,12,12]]},"reference":[{"key":"key20200713184448_b1-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 3","key":"key20200713184448_b2-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"iii27","DOI":"10.1093\/annonc\/mdu199","article-title":"Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Reck","year":"2014","journal-title":"Ann Oncol"},{"key":"key20200713184448_b3-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3816\/CLC.2003.n.022","article-title":"Anemia in lung cancer: Clinical impact and management","volume":"5","author":"Pirker","year":"2003","journal-title":"Clin Lung Cancer"},{"key":"key20200713184448_b4-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","article-title":"Anemia as an independent prognostic factor for survival in patients with cancer: A systemic, quantitative review","volume":"91","author":"Caro","year":"2001","journal-title":"Cancer"},{"key":"key20200713184448_b5-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ajh.23628","article-title":"Diagnosis and treatment of cancer-related anemia","volume":"89","author":"Gilreath","year":"2014","journal-title":"Am J Hematol"},{"key":"key20200713184448_b6-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3816\/CLC.2002.n.001","article-title":"Clinical benefits of epoetin alfa therapy in patients with lung cancer","volume":"3","author":"Crawford","year":"2002","journal-title":"Clin Lung Cancer"},{"key":"key20200713184448_b7-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1182\/blood-2010-08-300541","article-title":"American Society of Hematology\/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer","volume":"116","author":"Rizzo","year":"2010","journal-title":"Blood"},{"key":"key20200713184448_b8-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.critrevonc.2008.03.006","article-title":"The erythropoietin receptor in normal and cancer tissues","volume":"67","author":"Jelkmann","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20200713184448_b9-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/cncr.22832","article-title":"Expression and function of erythropoietin receptors in tumors: Implications for the use of erythropoiesis-stimulating agents in cancer patients","volume":"110","author":"Sinclair","year":"2007","journal-title":"Cancer"},{"key":"key20200713184448_b10-ijo-52-02-0518","first-page":"82","article-title":"The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells: From clinic to bench - a critical review","volume":"1806","author":"Szenajch","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"key20200713184448_b11-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1200\/JCO.2006.07.1514","article-title":"Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia","volume":"25","author":"Wright","year":"2007","journal-title":"J Clin Oncol"},{"key":"key20200713184448_b12-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/S0140-6736(09)60502-X","article-title":"Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: A meta-analysis of randomised trials","volume":"373","author":"Bohlius","year":"2009","journal-title":"Lancet"},{"key":"key20200713184448_b13-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1182\/blood-2007-08-109488","article-title":"Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology\/American Society of Clinical Oncology clinical practice guideline update","volume":"111","author":"Rizzo","year":"2008","journal-title":"Blood"},{"key":"key20200713184448_b14-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"628","DOI":"10.6004\/jnccn.2012.0064","article-title":"Cancer- and chemotherapy-induced anemia (Version 1.2018)","volume":"10","author":"Rodgers","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"key20200713184448_b15-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ejca.2006.10.012","article-title":"Preclinical studies of erythropoietin receptor expression in tumour cells: Impact on clinical use of erythropoietic proteins to correct cancer-related anaemia","volume":"43","author":"Osterborg","year":"2007","journal-title":"Eur J Cancer"},{"key":"key20200713184448_b16-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1046\/j.1523-1755.2000.00211.x","article-title":"Erythropoietin stimulates proliferation of human renal carcinoma cells","volume":"58","author":"Westenfelder","year":"2000","journal-title":"Kidney Int"},{"key":"key20200713184448_b17-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/pros.20310","article-title":"Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells","volume":"66","author":"Feldman","year":"2006","journal-title":"Prostate"},{"key":"key20200713184448_b18-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.canlet.2004.04.027","article-title":"Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells","volume":"214","author":"Acs","year":"2004","journal-title":"Cancer Lett"},{"key":"key20200713184448_b19-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/S0960-9822(02)00930-2","article-title":"Apoptosis protection by the Epo target Bcl-XL allows factor-independent differentiation of primary erythroblasts","volume":"12","author":"Dolznig","year":"2002","journal-title":"Curr Biol"},{"key":"key20200713184448_b20-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"e549","DOI":"10.1371\/journal.pone.0000549","article-title":"Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression","volume":"2","author":"Hardee","year":"2007","journal-title":"PLoS One"},{"key":"key20200713184448_b21-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/01.LAB.0000090156.94795.48","article-title":"Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival","volume":"83","author":"Batra","year":"2003","journal-title":"Lab Invest"},{"key":"key20200713184448_b22-ijo-52-02-0518","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1158\/1078-0432.993.11.3","article-title":"Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas","volume":"11","author":"Dagnon","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20200713184448_b23-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000092099","article-title":"Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin","volume":"3","author":"Dunlop","year":"2006","journal-title":"Neurodegener Dis"},{"issue":"Suppl 5","key":"key20200713184448_b24-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1634\/theoncologist.9-90005-4","article-title":"Tumor hypoxia: Causative factors, compensatory mechanisms, and cellular response","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"key20200713184448_b25-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1113\/jphysiol.2010.195057","article-title":"Regulation of erythropoietin production","volume":"589","author":"Jelkmann","year":"2011","journal-title":"J Physiol"},{"key":"key20200713184448_b26-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.canlet.2011.03.014","article-title":"Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells","volume":"308","author":"Wohlkoenig","year":"2011","journal-title":"Cancer Lett"},{"key":"key20200713184448_b27-ijo-52-02-0518","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood.V82.2.456.456","article-title":"Establishment and characterization of an erythropoietin-dependent subline, UT-7\/Epo, derived from human leukemia cell line, UT-7","volume":"82","author":"Komatsu","year":"1993","journal-title":"Blood"},{"key":"key20200713184448_b28-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1634\/stemcells.18-5-366","article-title":"Signaling induced by erythropoietin and stem cell factor in UT-7\/Epo cells: Transient versus sustained proliferation","volume":"18","author":"Erickson-Miller","year":"2000","journal-title":"Stem Cells"},{"key":"key20200713184448_b29-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"key20200713184448_b30-ijo-52-02-0518","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1158\/1535-7163.1525.3.12","article-title":"Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin","volume":"3","author":"Belenkov","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"key20200713184448_b31-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/cpt1979253351","article-title":"Kinetics of cisdichlorodiammineplatinum","volume":"25","author":"Gormley","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"key20200713184448_b32-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/clpt.1981.91","article-title":"Clinical kinetics on intact cisplatin and some related species","volume":"29","author":"Himmelstein","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key20200713184448_b33-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1182\/blood-2005-10-4066","article-title":"Anti-Epo receptor antibodies do not predict Epo receptor expression","volume":"107","author":"Elliott","year":"2006","journal-title":"Blood"},{"key":"key20200713184448_b34-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1182\/blood-2009-10-248674","article-title":"Absence of functional EpoR expression in human tumor cell lines","volume":"115","author":"Swift","year":"2010","journal-title":"Blood"},{"issue":"Suppl 3","key":"key20200713184448_b35-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1634\/theoncologist.13-S3-21","article-title":"Hypoxia and aggressive tumor phenotype: Implications for therapy and prognosis","volume":"13","author":"Vaupel","year":"2008","journal-title":"Oncologist"},{"key":"key20200713184448_b36-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1200\/JCO.2008.21.6945","article-title":"Erythroid-stimulating agents in cancer therapy: Potential dangers and biologic mechanisms","volume":"27","author":"Hadland","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20200713184448_b37-ijo-52-02-0518","doi-asserted-by":"crossref","first-page":"13639","DOI":"10.1016\/S0021-9258(19)38696-X","article-title":"Intermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomes","volume":"268","author":"Neumann","year":"1993","journal-title":"J Biol Chem"},{"key":"key20200713184448_b38-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1126\/science.1184913","article-title":"Covering a broad dynamic range: Information processing at the erythropoietin receptor","volume":"328","author":"Becker","year":"2010","journal-title":"Science"},{"key":"key20200713184448_b39-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1634\/stemcells.2006-0687","article-title":"Erythropoietin receptor expression in non-small cell lung carcinoma: A question of antibody specificity","volume":"25","author":"Brown","year":"2007","journal-title":"Stem Cells"},{"key":"key20200713184448_b40-ijo-52-02-0518","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/030089160208800214","article-title":"Erythropoietin and G-CSF receptors in human tumor cells: Expression and aspects regarding functionality","volume":"88","author":"Westphal","year":"2002","journal-title":"Tumori"},{"key":"key20200713184448_b41-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/01.cmr.0000222594.60611.c3","article-title":"Erythropoietin activates the phosphoinositide 3-kinase\/Akt pathway in human melanoma cells","volume":"16","author":"Kumar","year":"2006","journal-title":"Melanoma Res"},{"key":"key20200713184448_b42-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"39273","DOI":"10.1074\/jbc.M509446200","article-title":"Erythropoietin promotes MCF-7 breast cancer cell migration by an ERK\/ mitogen-activated protein kinase-dependent pathway and is primarily responsible for the increase in migration observed in hypoxia","volume":"280","author":"Lester","year":"2005","journal-title":"J Biol Chem"},{"key":"key20200713184448_b43-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/carcin\/bgg060","article-title":"Erythropoietin regulates tumour growth of human malignancies","volume":"24","author":"Yasuda","year":"2003","journal-title":"Carcinogenesis"},{"key":"key20200713184448_b44-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.2353\/ajpath.2009.080592","article-title":"RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells","volume":"174","author":"Paragh","year":"2009","journal-title":"Am J Pathol"},{"key":"key20200713184448_b45-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/mc.20607","article-title":"KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: Implication for combinatorial approach","volume":"49","author":"Yoon","year":"2010","journal-title":"Mol Carcinog"},{"key":"key20200713184448_b46-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/nar\/14.2.843","article-title":"Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene","volume":"14","author":"Valenzuela","year":"1986","journal-title":"Nucleic Acids Res"},{"key":"key20200713184448_b47-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0002-9440(10)64314-3","article-title":"Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression","volume":"162","author":"Acs","year":"2003","journal-title":"Am J Pathol"},{"key":"key20200713184448_b48-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"8987","DOI":"10.1038\/sj.onc.1208140","article-title":"The erythropoietin-receptor pathway modulates survival of cancer cells","volume":"23","author":"Pajonk","year":"2004","journal-title":"Oncogene"},{"key":"key20200713184448_b49-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1158\/1078-0432.CCR-05-1771","article-title":"Erythropoietin biology in cancer","volume":"12","author":"Hardee","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"Suppl 4","key":"key20200713184448_b50-ijo-52-02-0518","first-page":"41","article-title":"Effects of hematopoietic growth factors on malignant nonhematopoietic cells","volume":"19","author":"Berdel","year":"1992","journal-title":"Semin Oncol"},{"key":"key20200713184448_b51-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/BF01714953","article-title":"Studies on the role of recombinant human erythropoietin in the growth regulation of human nonhematopoietic tumor cells in vitro","volume":"63","author":"Berdel","year":"1991","journal-title":"Ann Hematol"},{"key":"key20200713184448_b52-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/sj.onc.1207294","article-title":"Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity","volume":"23","author":"Liu","year":"2004","journal-title":"Oncogene"},{"key":"key20200713184448_b53-ijo-52-02-0518","first-page":"92","article-title":"Effect of recombinant human erythropoietin on the growth of human tumor cell lines in vitro. Micro-titertec-tetrazolium assay","volume":"42","author":"Mundt","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"key20200713184448_b54-ijo-52-02-0518","first-page":"208","article-title":"Effect of recombinant human erythropoietin on hematopoietic and non-hematopoietic malignant cell growth in vitro","volume":"78","author":"Rosti","year":"1993","journal-title":"Haematologica"},{"key":"key20200713184448_b55-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/jcb.20133","article-title":"Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site","volume":"93","author":"R\u00f6ssler","year":"2004","journal-title":"J Cell Biochem"},{"key":"key20200713184448_b56-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1158\/1078-0432.CCR-05-2287","article-title":"Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs","volume":"12","author":"Gewirtz","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20200713184448_b57-ijo-52-02-0518","first-page":"208","article-title":"Effect of recombinant human erythropoietin on hematopoietic and non-hematopoietic malignant cell growth in vitro","volume":"78","author":"Rosti","year":"1993","journal-title":"Haematologica"},{"key":"key20200713184448_b58-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-4598-14-4","article-title":"Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1\u03b1 destabilization","volume":"14","author":"Fischer","year":"2015","journal-title":"Mol Cancer"},{"key":"key20200713184448_b59-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/bjc.2013.700","article-title":"Slice cultures from head and neck squamous cell carcinoma: A novel test system for drug susceptibility and mechanisms of resistance","volume":"110","author":"Gerlach","year":"2014","journal-title":"Br J Cancer"},{"key":"key20200713184448_b60-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/cam4.720","article-title":"Organotypic slice cultures of human gastric and esophago-gastric junction cancer","volume":"5","author":"Koerfer","year":"2016","journal-title":"Cancer Med"},{"key":"key20200713184448_b61-ijo-52-02-0518","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejpb.2016.11.013","article-title":"Tumor tissue slice cultures as a platform for analyzing tissue-penetration and biological activities of nanoparticles","volume":"112","author":"Merz","year":"2017","journal-title":"Eur J Pharm Biopharm"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T08:07:17Z","timestamp":1660118837000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2017.4225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,12]]},"references-count":61,"URL":"https:\/\/doi.org\/10.3892\/ijo.2017.4225","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"type":"print","value":"1019-6439"},{"type":"electronic","value":"1791-2423"}],"subject":[],"published":{"date-parts":[[2017,12,12]]}}}